{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:14:06Z","timestamp":1784189646773,"version":"3.55.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Guangxi Province","award":["2025GXNSFBA069420"],"award-info":[{"award-number":["2025GXNSFBA069420"]}]},{"name":"Project on Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation","award":["2024GXNSFDA010040"],"award-info":[{"award-number":["2024GXNSFDA010040"]}]},{"name":"the 111 Projects","award":["D17011"],"award-info":[{"award-number":["D17011"]}]},{"name":"the Youth Program of Scientific Research Foundation of Guangxi Medical University Cancer Hospital","award":["YQJ2024-09"],"award-info":[{"award-number":["YQJ2024-09"]}]},{"name":"the Youth Science Foundation of Guangxi Medical University","award":["GXMUYSF202503"],"award-info":[{"award-number":["GXMUYSF202503"]}]},{"name":"Joint Project on Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation","award":["2023GXNSFBA026049"],"award-info":[{"award-number":["2023GXNSFBA026049"]}]},{"name":"the Promoting Project of Basic Capacity for Young and Middle-aged University Teachers in Guangxi","award":["2021KY0099"],"award-info":[{"award-number":["2021KY0099"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16212-x","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T22:54:52Z","timestamp":1779490492000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Potentially functional variants of CYP2A6 and ABHD12 in the arachidonic acid metabolism pathway genes predict the survival of HBV-related hepatocellular carcinoma patients"],"prefix":"10.1186","volume":"26","author":[{"given":"Junzheng","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuping","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyan","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanji","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiqin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"issue":"3","key":"16212_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"16212_CR2","first-page":"221","volume":"46","author":"RS Zheng","year":"2024","unstructured":"Zheng RS, Chen R, Han BF, et al. [Cancer incidence and mortality in China, 2022]. Zhonghua Zhong Liu Za Zhi. 2024;46(3):221\u201331.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"16212_CR3","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ejca.2021.11.023","volume":"161","author":"H Rumgay","year":"2022","unstructured":"Rumgay H, Ferlay J, De Martel C, et al. Global, regional and national burden of primary liver cancer by subtype. Eur J Cancer. 2022;161:108\u201318.","journal-title":"Eur J Cancer"},{"key":"16212_CR4","doi-asserted-by":"publisher","first-page":"906778","DOI":"10.3389\/fonc.2022.906778","volume":"12","author":"J Lin","year":"2022","unstructured":"Lin J, Zhang H, Yu H, et al. Epidemiological Characteristics of Primary Liver Cancer in Mainland China From 2003 to 2020: A Representative Multicenter Study. Front Oncol. 2022;12:906778.","journal-title":"Front Oncol"},{"issue":"5","key":"16212_CR5","doi-asserted-by":"publisher","first-page":"e555","DOI":"10.1016\/S2214-109X(18)30127-X","volume":"6","author":"H Zeng","year":"2018","unstructured":"Zeng H, Chen W, Zheng R, et al. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries. Lancet Glob Health. 2018;6(5):e555\u201367.","journal-title":"Lancet Glob Health"},{"issue":"5","key":"16212_CR6","first-page":"893","volume":"40","author":"NH China","year":"2024","unstructured":"China NH, C O T P S, R O. Standard for diagnosis and treatment of primary liver cancer (2024 edition). J Clin Hepatol. 2024;40(5):893\u2013918.","journal-title":"J Clin Hepatol"},{"issue":"10","key":"16212_CR7","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.jacbts.2020.05.013","volume":"5","author":"AJ Marian","year":"2020","unstructured":"Marian AJ. Clinical Interpretation and Management of Genetic Variants. JACC Basic Transl Sci. 2020;5(10):1029\u201342.","journal-title":"JACC Basic Transl Sci"},{"key":"16212_CR8","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1186\/1471-2407-12-606","volume":"12","author":"M Sakai","year":"2012","unstructured":"Sakai M, Kakutani S, Horikawa C, et al. Arachidonic acid and cancer risk: a systematic review of observational studies. BMC Cancer. 2012;12:606.","journal-title":"BMC Cancer"},{"key":"16212_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jare.2018.03.005","volume":"11","author":"VS Hanna","year":"2018","unstructured":"Hanna VS, Hafez E. a A. Synopsis of arachidonic acid metabolism: A review. J Adv Res. 2018;11:23\u201332.","journal-title":"J Adv Res"},{"issue":"4","key":"16212_CR10","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3748\/wjg.v25.i4.433","volume":"25","author":"P Prieto","year":"2019","unstructured":"Prieto P, Ja\u00e9n RI, Calle D, et al. Interplay between post-translational cyclooxygenase-2 modifications and the metabolic and proteomic profile in a colorectal cancer cohort. World J Gastroenterol. 2019;25(4):433\u201346.","journal-title":"World J Gastroenterol"},{"key":"16212_CR11","doi-asserted-by":"crossref","unstructured":"St Denis A, Simonette R, Rady PL, Tyring SK. The role of prostaglandin pathway and EP receptors in skin cancer development. Int J Dermatol. 2025;64(7):1186\u20131200.","DOI":"10.1111\/ijd.17711"},{"issue":"2\u20133","key":"16212_CR12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10555-018-9747-8","volume":"37","author":"YJ Xu","year":"2018","unstructured":"Xu YJ, Zheng Z, Cao C, et al. Bioanalytical insights into the association between eicosanoids and pathogenesis of hepatocellular carcinoma. Cancer Metastasis Rev. 2018;37(2\u20133):269\u201377.","journal-title":"Cancer Metastasis Rev"},{"issue":"5","key":"16212_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/cr.2010.49","volume":"20","author":"C Shan","year":"2010","unstructured":"Shan C, Xu F, Zhang S, et al. Hepatitis B virus X protein promotes liver cell proliferation via a positive cascade loop involving arachidonic acid metabolism and p-ERK1\/2. Cell Res. 2010;20(5):563\u201375.","journal-title":"Cell Res"},{"key":"16212_CR14","doi-asserted-by":"publisher","first-page":"1124214","DOI":"10.3389\/fphar.2023.1124214","volume":"14","author":"CG Leineweber","year":"2023","unstructured":"Leineweber CG, Rabehl M, Pietzner A, et al. Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma. Front Pharmacol. 2023;14:1124214.","journal-title":"Front Pharmacol"},{"issue":"7","key":"16212_CR15","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1158\/1541-7786.MCR-18-1127","volume":"17","author":"AP Chiu","year":"2019","unstructured":"Chiu AP, Tschida BR, Sham TT, et al. HBx-K130M\/V131I Promotes Liver Cancer in Transgenic Mice via AKT\/FOXO1 Signaling Pathway and Arachidonic Acid Metabolism. Mol Cancer Res. 2019;17(7):1582\u201393.","journal-title":"Mol Cancer Res"},{"issue":"2","key":"16212_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0378-1119(99)00219-X","volume":"234","author":"AJ Brookes","year":"1999","unstructured":"Brookes AJ. The essence of SNPs. Gene. 1999;234(2):177\u201386.","journal-title":"Gene"},{"issue":"12","key":"16212_CR17","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/35103535","volume":"2","author":"AC Syv\u00e4nen","year":"2001","unstructured":"Syv\u00e4nen AC. Accessing genetic variation: genotyping single nucleotide polymorphisms. Nat Rev Genet. 2001;2(12):930\u201342.","journal-title":"Nat Rev Genet"},{"issue":"8","key":"16212_CR18","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1002\/mc.23208","volume":"59","author":"X Liu","year":"2020","unstructured":"Liu X, Qian D, Liu H, et al. Genetic variants of the peroxisome proliferator-activated receptor (PPAR) signaling pathway genes and risk of pancreatic cancer. Mol Carcinog. 2020;59(8):930\u20139.","journal-title":"Mol Carcinog"},{"issue":"6","key":"16212_CR19","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1002\/ijc.33702","volume":"149","author":"R Mu","year":"2021","unstructured":"Mu R, Liu H, Luo S, et al. Genetic variants of CHEK1, PRIM2 and CDK6 in the mitotic phase-related pathway are associated with nonsmall cell lung cancer survival. Int J Cancer. 2021;149(6):1302\u201312.","journal-title":"Int J Cancer"},{"key":"16212_CR20","doi-asserted-by":"publisher","first-page":"e930052","DOI":"10.12659\/MSM.930052","volume":"27","author":"Z Liu","year":"2021","unstructured":"Liu Z, Ye J, Khan AA, et al. Genome-Wide Profiling of Alternative Splicing Signatures Associated with Prognosis and Immune Microenvironment of Hepatocellular Carcinoma. Med Sci Monit. 2021;27:e930052.","journal-title":"Med Sci Monit"},{"issue":"6","key":"16212_CR21","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.7150\/jca.28919","volume":"10","author":"K Huang","year":"2019","unstructured":"Huang K, Liao X, Han C, et al. Genetic variants and Expression of Cytochrome p450 Oxidoreductase Predict Postoperative Survival in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma. J Cancer. 2019;10(6):1453\u201365.","journal-title":"J Cancer"},{"key":"16212_CR22","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.12659\/MSM.915511","volume":"25","author":"J Wei","year":"2019","unstructured":"Wei J, Sheng Y, Li J, et al. Genome-Wide Association Study Identifies a Genetic Prediction Model for Postoperative Survival in Patients with Hepatocellular Carcinoma. Med Sci Monit. 2019;25:2452\u201378.","journal-title":"Med Sci Monit"},{"issue":"6","key":"16212_CR23","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s00204-023-03469-5","volume":"97","author":"Q Lin","year":"2023","unstructured":"Lin Q, Qiu M, Wei X, et al. Genetic variants of SOS2, MAP2K1 and RASGRF2 in the RAS pathway genes predict survival of HBV-related hepatocellular carcinoma patients. Arch Toxicol. 2023;97(6):1599\u2013611.","journal-title":"Arch Toxicol"},{"key":"16212_CR24","doi-asserted-by":"publisher","first-page":"990160","DOI":"10.3389\/fonc.2022.990160","volume":"12","author":"Q Huang","year":"2022","unstructured":"Huang Q, Liu Y, Qiu M, et al. Potentially functional variants of MAP3K14 in the NF-\u03baB signaling pathway genes predict survival of HBV-related hepatocellular carcinoma patients. Front Oncol. 2022;12:990160.","journal-title":"Front Oncol"},{"issue":"4","key":"16212_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/carcin\/bgae003","volume":"45","author":"J Wei","year":"2024","unstructured":"Wei J, Wen Q, Zhan S, et al. Functional genetic variants of the disulfidptosis-related INF2 gene predict survival of hepatitis B virus-related hepatocellular carcinoma. Carcinogenesis. 2024;45(4):199\u2013209.","journal-title":"Carcinogenesis"},{"issue":"6235","key":"16212_CR26","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1126\/science.1262110","volume":"348","author":"Human genomics","year":"2015","unstructured":"Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science. 2015;348(6235):648\u201360.","journal-title":"Science"},{"key":"16212_CR27","doi-asserted-by":"crossref","unstructured":"Xu Z, Taylor JA. SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res. 2009;37(Web Server issue):W600\u20135.","DOI":"10.1093\/nar\/gkp290"},{"issue":"Database issue","key":"16212_CR28","doi-asserted-by":"publisher","first-page":"D930","DOI":"10.1093\/nar\/gkr917","volume":"40","author":"LD Ward","year":"2012","unstructured":"Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2012;40(Database issue):D930\u20134.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"16212_CR29","doi-asserted-by":"publisher","first-page":"D877","DOI":"10.1093\/nar\/gkv1340","volume":"44","author":"LD Ward","year":"2016","unstructured":"Ward LD, Kellis M. HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease. Nucleic Acids Res. 2016;44(D1):D877\u201381.","journal-title":"Nucleic Acids Res"},{"issue":"269","key":"16212_CR30","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1.","journal-title":"Sci Signal"},{"key":"16212_CR31","doi-asserted-by":"crossref","unstructured":"Chandrashekar DS, Bashel B, Balasubramanya S a. UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia. 2017;19(8):649\u201358.","DOI":"10.1016\/j.neo.2017.05.002"},{"issue":"3","key":"16212_CR32","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1007\/s11357-023-00742-4","volume":"45","author":"B Gy\u0151rffy","year":"2023","unstructured":"Gy\u0151rffy B. Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer. Geroscience. 2023;45(3):1889\u201398.","journal-title":"Geroscience"},{"issue":"2","key":"16212_CR33","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1086\/519024","volume":"81","author":"J Wakefield","year":"2007","unstructured":"Wakefield J. A Bayesian measure of the probability of false discovery in genetic epidemiology studies. Am J Hum Genet. 2007;81(2):208\u201327.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"16212_CR34","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/00001648-199605000-00012","volume":"7","author":"SF Assmann","year":"1996","unstructured":"Assmann SF, Hosmer DW, Lemeshow S, Mundt KA. Confidence intervals for measures of interaction. Epidemiology. 1996;7(3):286\u201390.","journal-title":"Epidemiology"},{"issue":"18","key":"16212_CR35","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1093\/bioinformatics\/btq419","volume":"26","author":"RJ Pruim","year":"2010","unstructured":"Pruim RJ, Welch RP, Sanna S, et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics. 2010;26(18):2336\u20137.","journal-title":"Bioinformatics"},{"issue":"3","key":"16212_CR36","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/s41380-024-02703-5","volume":"30","author":"JG Pouget","year":"2025","unstructured":"Pouget JG, Giratallah H, Langlois AWR, et al. Fine-mapping the CYP2A6 regional association with nicotine metabolism among African American smokers. Mol Psychiatry. 2025;30(3):943\u201353.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"16212_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2174\/138920013804545223","volume":"14","author":"A Abu-Bakar","year":"2013","unstructured":"Abu-Bakar A, Hakkola J, Juvonen R, et al. Function and regulation of the Cyp2a5\/CYP2A6 genes in response to toxic insults in the liver. Curr Drug Metab. 2013;14(1):137\u201350.","journal-title":"Curr Drug Metab"},{"issue":"3","key":"16212_CR38","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/2211-5463.13089","volume":"11","author":"T Jiang","year":"2021","unstructured":"Jiang T, Zhu AS, Yang CQ, et al. Cytochrome P450 2A6 is associated with macrophage polarization and is a potential biomarker for hepatocellular carcinoma. FEBS Open Bio. 2021;11(3):670\u201383.","journal-title":"FEBS Open Bio"},{"issue":"3","key":"16212_CR39","first-page":"263","volume":"10","author":"S Kadlubar","year":"2009","unstructured":"Kadlubar S, Anderson JP, Sweeney C, et al. Phenotypic CYP2A6 variation and the risk of pancreatic cancer. Jop. 2009;10(3):263\u201370.","journal-title":"Jop"},{"issue":"4","key":"16212_CR40","first-page":"377","volume":"11","author":"S Nowell","year":"2002","unstructured":"Nowell S, Sweeney C, Hammons G, et al. CYP2A6 activity determined by caffeine phenotyping: association with colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11(4):377\u201383.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"16212_CR41","first-page":"890","volume":"11","author":"N Ariyoshi","year":"2002","unstructured":"Ariyoshi N, Miyamoto M, Umetsu Y, et al. Genetic polymorphism of CYP2A6 gene and tobacco-induced lung cancer risk in male smokers. Cancer Epidemiol Biomarkers Prev. 2002;11(9):890\u20134.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"16212_CR42","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/1097-0215(20010320)95:2<96::AID-IJC1017>3.0.CO;2-2","volume":"95","author":"W Tan","year":"2001","unstructured":"Tan W, Chen GF, Xing DY, et al. Frequency of CYP2A6 gene deletion and its relation to risk of lung and esophageal cancer in the Chinese population. Int J Cancer. 2001;95(2):96\u2013101.","journal-title":"Int J Cancer"},{"issue":"22","key":"16212_CR43","first-page":"8057","volume":"63","author":"H Wang","year":"2003","unstructured":"Wang H, Tan W, Hao B, et al. Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK. Cancer Res. 2003;63(22):8057\u201361.","journal-title":"Cancer Res"},{"issue":"3","key":"16212_CR44","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/s41418-021-00871-3","volume":"29","author":"TJ Humpton","year":"2022","unstructured":"Humpton TJ, Hall H, Kiourtis C, et al. p53-mediated redox control promotes liver regeneration and maintains liver function in response to CCl(4). Cell Death Differ. 2022;29(3):514\u201326.","journal-title":"Cell Death Differ"},{"issue":"12","key":"16212_CR45","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1158\/1535-7163.MCT-15-0274","volume":"14","author":"T Yan","year":"2015","unstructured":"Yan T, Lu L, Xie C, et al. Severely Impaired and Dysregulated Cytochrome P450 Expression and Activities in Hepatocellular Carcinoma: Implications for Personalized Treatment in Patients. Mol Cancer Ther. 2015;14(12):2874\u201386.","journal-title":"Mol Cancer Ther"},{"key":"16212_CR46","doi-asserted-by":"crossref","unstructured":"Liu YF, Feng LY, Zhang WY, et al. CYP2A6 suppresses hepatocellular carcinoma via inhibiting SRC\/Wnt\/\u03b2-Catenin pathway. Acta Pharmacol Sin. 2025;46(7):2029\u20132040.","DOI":"10.1038\/s41401-025-01524-8"},{"issue":"1","key":"16212_CR47","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","volume":"6","author":"B Wang","year":"2021","unstructured":"Wang B, Wu L, Chen J, et al. Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets. Signal Transduct Target Ther. 2021;6(1):94.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"16212_CR48","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12944-025-02463-3","volume":"24","author":"UN Das","year":"2025","unstructured":"Das UN, Hacim\u00fcft\u00fcoglu A, Akpinar E, et al. Crosstalk between renin and arachidonic acid (and its metabolites). Lipids Health Dis. 2025;24(1):52.","journal-title":"Lipids Health Dis"},{"issue":"3","key":"16212_CR49","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ajhg.2010.08.002","volume":"87","author":"T Fiskerstrand","year":"2010","unstructured":"Fiskerstrand T, H\u2019mida-Ben Brahim D, Johansson S, et al. Mutations in ABHD12 cause the neurodegenerative disease PHARC: An inborn error of endocannabinoid metabolism. Am J Hum Genet. 2010;87(3):410\u20137.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"16212_CR50","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1073\/pnas.1217121110","volume":"110","author":"JL Blankman","year":"2013","unstructured":"Blankman JL, Long JZ, Trauger SA, et al. ABHD12 controls brain lysophosphatidylserine pathways that are deregulated in a murine model of the neurodegenerative disease PHARC. Proc Natl Acad Sci U S A. 2013;110(4):1500\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"16212_CR51","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.apsb.2019.10.006","volume":"10","author":"H Deng","year":"2020","unstructured":"Deng H, Li W. Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders. Acta Pharm Sin B. 2020;10(4):582\u2013602.","journal-title":"Acta Pharm Sin B"},{"issue":"5","key":"16212_CR52","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.21873\/anticanres.14231","volume":"40","author":"S Jun","year":"2020","unstructured":"Jun S, Kim SW, Lim JY, Park SJ. ABHD12 Knockdown Suppresses Breast Cancer Cell Proliferation, Migration and Invasion. Anticancer Res. 2020;40(5):2601\u201311.","journal-title":"Anticancer Res"},{"issue":"1","key":"16212_CR53","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s12672-024-01211-w","volume":"15","author":"T Mao","year":"2024","unstructured":"Mao T, Zhang M, Peng Z, et al. Integrative analysis of ferroptosis-related genes reveals that ABHD12 is a novel prognostic biomarker and facilitates hepatocellular carcinoma tumorigenesis. Discov Oncol. 2024;15(1):330.","journal-title":"Discov Oncol"},{"issue":"7584","key":"16212_CR54","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nature16166","volume":"529","author":"S Wu","year":"2016","unstructured":"Wu S, Powers S, Zhu W, Hannun YA. Substantial contribution of extrinsic risk factors to cancer development. Nature. 2016;529(7584):43\u20137.","journal-title":"Nature"},{"issue":"7","key":"16212_CR55","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10654-014-9934-z","volume":"29","author":"X Song","year":"2014","unstructured":"Song X, Pukkala E, Dyba T, et al. Body mass index and cancer incidence: the FINRISK study. Eur J Epidemiol. 2014;29(7):477\u201387.","journal-title":"Eur J Epidemiol"},{"key":"16212_CR56","doi-asserted-by":"crossref","unstructured":"Banerjee A, Farci P. Fibrosis and hepatocarcinogenesis: role of gene-environment interactions in liver disease progression. Int J Mol Sci. 2024;25(16):8641.","DOI":"10.3390\/ijms25168641"},{"issue":"1","key":"16212_CR57","doi-asserted-by":"publisher","first-page":"2455539","DOI":"10.1080\/07853890.2025.2455539","volume":"57","author":"J Wang","year":"2025","unstructured":"Wang J, Qiu K, Zhou S, et al. Risk factors for hepatocellular carcinoma: an umbrella review of systematic review and meta-analysis. Ann Med. 2025;57(1):2455539.","journal-title":"Ann Med"},{"issue":"1","key":"16212_CR58","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s15010-019-01345-y","volume":"48","author":"E Sagnelli","year":"2020","unstructured":"Sagnelli E, Macera M, Russo A, et al. Epidemiological and etiological variations in hepatocellular carcinoma. Infection. 2020;48(1):7\u201317.","journal-title":"Infection"},{"key":"16212_CR59","doi-asserted-by":"crossref","unstructured":"Zelber-Sagi S, Noureddin M, Shibolet O. Lifestyle and hepatocellular carcinoma what is the evidence and prevention recommendations. Cancers (Basel). 2021;14(1):103.","DOI":"10.3390\/cancers14010103"},{"key":"16212_CR60","doi-asserted-by":"crossref","unstructured":"Tanner JA, Tyndale RF. Variation in CYP2A6 activity and personalized medicine. J Pers Med. 2017;7(4):18.","DOI":"10.3390\/jpm7040018"},{"issue":"4","key":"16212_CR61","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/FPC.0000000000000269","volume":"27","author":"T Taghavi","year":"2017","unstructured":"Taghavi T, St Helen G, Benowitz NL, Tyndale RF. Effect of UGT2B10, UGT2B17, FMO3, and OCT2 genetic variation on nicotine and cotinine pharmacokinetics and smoking in African Americans. Pharmacogenet Genomics. 2017;27(4):143\u201354.","journal-title":"Pharmacogenet Genomics"},{"issue":"10","key":"16212_CR62","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.2217\/14622416.8.10.1385","volume":"8","author":"JC Mwenifumbo","year":"2007","unstructured":"Mwenifumbo JC, Tyndale RF. Genetic variability in CYP2A6 and the pharmacokinetics of nicotine. Pharmacogenomics. 2007;8(10):1385\u2013402.","journal-title":"Pharmacogenomics"},{"issue":"4","key":"16212_CR63","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1158\/0008-5472.CAN-23-0900","volume":"84","author":"M Du","year":"2024","unstructured":"Du M, Xin J, Zheng R, et al. CYP2A6 Activity and Cigarette Consumption Interact in Smoking-Related Lung Cancer Susceptibility. Cancer Res. 2024;84(4):616\u201325.","journal-title":"Cancer Res"},{"key":"16212_CR64","doi-asserted-by":"crossref","unstructured":"Yamamoto S, Koyanagi YN, Iwashita Y et al. Smoking behavior-related genetic variants and lung cancer risk in Japanese: an assessment by mediation analysis. Carcinogenesis. 2025;46(2):bgaf011.","DOI":"10.1093\/carcin\/bgaf011"},{"issue":"1","key":"16212_CR65","doi-asserted-by":"publisher","first-page":"97","DOI":"10.35946\/arcr.v35.1.11","volume":"35","author":"BJ Curtis","year":"2013","unstructured":"Curtis BJ, Zahs A, Kovacs EJ. Epigenetic targets for reversing immune defects caused by alcohol exposure. Alcohol Res. 2013;35(1):97\u2013113.","journal-title":"Alcohol Res"},{"issue":"1","key":"16212_CR66","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jhep.2015.08.028","volume":"64","author":"U Saran","year":"2016","unstructured":"Saran U, Humar B, Kolly P, Dufour JF. Hepatocellular carcinoma and lifestyles. J Hepatol. 2016;64(1):203\u201314.","journal-title":"J Hepatol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16212-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16212-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16212-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:02:46Z","timestamp":1784188966000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16212-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16212"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16212-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and was approved by the Institutional Review Board of Guangxi Medical University Cancer Hospital (approval number: KY2025629), and written informed consent was obtained from each participant before data collection.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"848"}}